Financial News
Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)
Headline News about Vistagen Therapeutics, Inc. - Common Stock
VistaGen Therapeutics Earnings Perspective: Return On Capital Employed
December 22, 2022
Via Benzinga
Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma Acquisition
December 21, 2022
Via Benzinga
Independent Biostatisticians Recommend Vistagen Continue Late-Stage Anxiety Trial
September 08, 2022
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Via Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
